No Link Between Prenatal PFOA/PFOS Exposure and Baby Development
Author Information
Author(s): Brown Valerie J.
Primary Institution: International Epidemiology Institute
Hypothesis
Are maternal plasma levels of PFOA and PFOS associated with delayed early development in babies?
Conclusion
The study found no significant association between maternal PFOA/PFOS levels and early developmental milestones in children.
Supporting Evidence
- 98% of the U.S. population has detectable levels of PFOA and PFOS.
- Previous studies hinted at developmental effects from PFOA and PFOS.
- The study measured PFOA and PFOS levels in maternal blood samples during the first trimester.
- Child development was assessed through interviews when children were 6 and 18 months old.
- Significant differences in PFOA and PFOS levels were found between first-time mothers and those with older children.
Takeaway
The study looked at whether chemicals in pregnant mothers' blood affect how babies develop, and it found no clear link.
Methodology
The study involved measuring PFOA and PFOS levels in maternal blood and assessing child development through interviews.
Potential Biases
Funding from the 3M Company, the original manufacturer of PFOA and PFOS, may introduce bias.
Limitations
The presence of older siblings may confound results, and the study suggests more sensitive measures are needed.
Participant Demographics
Participants were mother-baby pairs from the Danish National Birth Cohort, primarily first-time mothers.
Want to read the original?
Access the complete publication on the publisher's website